Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for VAREX IMAGING (VREX : NSDQ)

• Company Description    Varex Imaging Corporation is an innovator, designer and manufacturer of X-ray imaging components which include tubes, digital flat panel detectors and other image processing solutions. Its components are used in medical imaging as well as industrial and security imaging applications. The company operates primarily in North America, Europe and Asia. Varex Imaging Corporation is based in Salt Lake City, United States. Number of Employees: 2,300

• Price / Volume Information    Yesterday's Closing Price: $11.97 Daily Weekly Monthly 20 Day Moving Average: 215,484 shares Shares Outstanding: 41.50 (millions) Market Capitalization: $496.76 (millions) Beta: 0.98 52 Week High: $16.93 52 Week Low: $6.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.73% 7.83% 12 Week 10.12% 5.55% Year To Date -17.96% -28.29%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1678 SOUTH PIONEER ROAD - SALT LAKE CITY,UT 84104 USA ph: 801-972-5000 fax: - howard.goldman@vareximaging.com http://www.vertexinc.com

• General Corporate Information    Officers Sunny S. Sanyal - President and Chief Executive Officer and Director Walter M Rosebrough - Chairman of the Board Shubham Maheshwari - Chief Financial Officer Kathleen L. Bardwell - Director Jocelyn D. Chertoff - Director Peer Information VAREX IMAGING (BJCT) VAREX IMAGING (CADMQ) VAREX IMAGING (APNO) VAREX IMAGING (UPDC) VAREX IMAGING (IMTIQ) VAREX IMAGING (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 92214X106 SIC: 3679 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/18/25 Share - Related Items Shares Outstanding: 41.50 Most Recent Split Date: (:1) Beta: 0.98 Market Capitalization: $496.76 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.21 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.97 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/18/25

• Fundamental Ratios P/E Current FY Estimate: 12.34 Trailing 12 Months: 17.10 PEG Ratio: - Price Ratios Price/Book: 1.05 Price/Cash Flow: 8.71 Price / Sales: 0.60 EPS Growth vs. Year Ago Period: 28.57% vs. Previous Quarter: -30.77% Sales Growth vs. Year Ago Period: -2.92% vs. Previous Quarter: -4.65% ROE 09/30/25 - - 06/30/25 - 5.54 03/31/25 - 4.91 ROA 09/30/25 - - 06/30/25 - 2.38 03/31/25 - 2.16 Current Ratio 09/30/25 - - 06/30/25 - 3.51 03/31/25 - 4.05 Quick Ratio 09/30/25 - - 06/30/25 - 1.82 03/31/25 - 2.36 Operating Margin 09/30/25 - - 06/30/25 - 3.60 03/31/25 - 3.36 Net Margin 09/30/25 - - 06/30/25 - -16.13 03/31/25 - -5.08 Pre-Tax Margin 09/30/25 - - 06/30/25 - -8.62 03/31/25 - 2.01 Book Value 09/30/25 - - 06/30/25 - 11.40 03/31/25 - 13.69 Inventory Turnover 09/30/25 - - 06/30/25 - 1.92 03/31/25 - 1.97 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.78 03/31/25 - 1.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 43.81 03/31/25 - 50.08

Powered by Zacks Investment Research ©